The story of Sildenafil presents a challenging picture for those considering investment. While the initial introduction generated substantial profits, the expiration of its intellectual property protection opened the https://sahilxazb551201.blogoscience.com/48547427/the-copyright-and-big-pharma-a-volatile-opportunity